RSPO4 and neoplasm: By sphere formation assay, we found that FUm1/2 mutant expression lost the inhibitory effect of RSPO4 on cancer cell stemness of both LGR4+/LGR5- and LGR4-/LGR5+ tumor cells (Fig. 6B).